The remaining comparisons between AF and AF+CMS groups, and the CMS and AF+CMS groups lost the significant differences that were caught before the adjustment for multiple comparisons and showed non-significant difference in the IL-17F after adjustment for multiple comparisons (multiple comparison, adjusted P = 0.102 for the comparisons between AF and AF+CMS, and P = 0.326 for the comparisons between AF+CMS and CMS). This evidence concerns the gene IL17F and atrial fibrillation.